Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022206

Expand all

RAPAFLO (SILODOSIN)
4MG Marketing Status: Prescription

Active Ingredient: SILODOSIN
Proprietary Name: RAPAFLO
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 4MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022206
Product Number: 001
Approval Date: Oct 8, 2008
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

RAPAFLO (SILODOSIN)
8MG Marketing Status: Prescription

Active Ingredient: SILODOSIN
Proprietary Name: RAPAFLO
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 8MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022206
Product Number: 002
Approval Date: Oct 8, 2008
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English